Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$480 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.[1][2][3]

Background

Established in 1958, Deva Holding A.S. is Turkey’s second-largest pharmaceutical company and is primarily engaged in the production and distribution of pharmaceutical and veterinary products.[4][5]

References

  1. ^ "Antibiotic Long Distance Run". Fortune Magazine. 19 July 2019. Archived from the original on 2019-09-05. Retrieved 15 September 2019.
  2. ^ "5 Minutes Interview with: Philipp Haas - Deva". Pharma Horizon Magazine. 4 May 2017. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
  3. ^ "Philipp Haas – Chairman & CEO, DEVA, Turkey". Pharma Boardroom Magazine. 29 November 2018. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
  4. ^ "» 5 minutes interview with: Philipp Haas – DEVA". TKS Publisher. Retrieved 2019-10-28.
  5. ^ "DEVA.IS - Deva Holding AS Profile | Reuters". www.reuters.com. Retrieved 2019-10-28.


Allikas: https://en.wikipedia.org/wiki/Deva_Holding_A.S.
No tags for this post.